Skip to Content

M L 4 (Levothyroxine Sodium 25 mcg (0.025 mg))

Pill with imprint M L 4 is Orange, Capsule-shape and has been identified as Levothyroxine Sodium 25 mcg (0.025 mg). It is supplied by Mylan Pharmaceuticals Inc..

Levothyroxine is used in the treatment of hashimoto's disease; underactive thyroid; hypothyroidism, after thyroid removal; tsh suppression; thyroid suppression test (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 25 mcg (0.025 mg) is not a controlled substance under the Controlled Substances Act (CSA).

Images for M L 4

Levothyroxine sodium 25 mcg (0.025 mg) M L 4 Front
Levothyroxine sodium 25 mcg (0.025 mg) M L 4 Back
Levothyroxine sodium 25 mcg (0.025 mg) M L 4
Levothyroxine sodium 25 mcg (0.025 mg) M L 4

Levothyroxine Sodium

Imprint:
M L 4
Strength:
25 mcg (0.025 mg)
Color:
Orange
Size:
9.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Thyroid drugs
Pregnancy Category:
A - Studies show no risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
butylated hydroxyanisole
silicon dioxide
crospovidone
magnesium stearate
mannitol
microcrystalline cellulose
povidone
sodium lauryl sulfate
sucrose
FD&C Yellow No. 6
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0444 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide